(Total Views: 548)
Posted On: 08/20/2022 6:50:39 PM
Post# of 145903
Cancer is frequently associated with Inclusion Body Myositis. Some of the trademark biomarkers, associated with the condition, indicate that Leronlimab might help Peter Frampton. High CCR5 expression, T Cell deregulation, and chronic inflammation are present. Current treatment is immune suppressing steroids. I didn't see this in Ohm20's list. However, I may have an outdated copy.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6374100/
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5516174/
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6374100/
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5516174/
![](/m/images/thumb-up.png)
![](/m/images/thumb-down.png)